Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. NIM scientist Prof Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.
In the treatment of cancer, there are still several limitations. Especially the delivery of sufficient amounts of active chemotherapeutic drug is difficult. After the conventional intravenous administration, the therapeutic formulation faces some hurdles before reaching the target site. In most cases, the blood circulation time of the active compound is rather short, and a substantial amount of the remaining active drug accumulates in non-target tissues and leads to the known unpleasant and unwanted side-effects in patients.
Therefore, the group of Professor Olivia Merkel focuses on the development of stable and targeted nanocarrier formulations and alternative administration routes. One approach is the targeting of specific sugar receptors expressed on several cancer cells, the mannose and mannose-6-phosphate receptors. The new publication in Advanced Healthcare Materials (“Mannose and Mannose-6-Phosphate Receptor–Targeted Drug Delivery Systems and Their Application in Cancer Therapy”) provides a nice overview of the field and presents first results of a new approach tested in the Merkel Lab.
Image Credit: C Hohmann
News This Week
Think that human augmentation is still decades away? Think again. This week, government leaders met with experts and innovators ahead of the World Government Summit in Dubai. Their goal? To determine the future of artificial [...]
It may sound contradictory, but diamonds are the key to a new technique that could provide a very-low-cost alternative to multimillion-dollar medical imaging and drug-discovery devices. An international team led by scientists at the [...]
The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, [...]
Circulating tumour cells (CTCs) are cancer cells that escape from primary tumour sites and enter the bloodstream. This metastasis is responsible for the majority of deaths from cancer. Monitoring the level of CTC levels [...]
Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal [...]
The University of Warwick and QuantIC researchers at Heriot Watt University and the University of Glasgow performed a study in optical sensing, which could considerably enhance the precision of measuring nanoscopic structures. QuantIC is [...]